Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
cancer
4
×
life sciences
national
4
×
national blog main
national top stories
san francisco blog main
san francisco top stories
boston blog main
boston top stories
texas blog main
texas top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
keytruda
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
wisconsin blog main
wisconsin top stories
arena pharmaceuticals
blueprint medicines
cancer immunotherapy
cardiovascular disease
checkpoint inhibitors
colorectal cancer
companion diagnostic
crispr
crispr therapeutics
What
cancer
medicine
4
×
drug
fda
genetic
new
patients
risks
allison
approved
cancers
cas
cells
countless
crispr
deeper
defect
dna
drive
edited
editing
eisai
fears
fight
fingerprint
flag
flags
gene
going
guardian
harnessing
higher
honjo
honors
human
immune
immunotherapy
incidence
known
lab
Language
unset
Current search:
national
×
medicine
×
cancer
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues
@xconomy.com
5 years ago
Nobel Medicine Prize Honors Cancer Immunotherapy Pioneers Allison & Honjo
@xconomy.com
5 years ago
CRISPR Risks? Researchers Stoke Fears of Cancer in Gene-Edited Cells
